Recombinant foot-and-mouth disease virus non-toxic strain with heat-resistant phenotypic stable inheritance and negative marker and O/A type foot-and-mouth disease bivalent inactivated vaccine

A foot-and-mouth disease virus, avirulent strain technology, applied in the direction of virus/phage, vaccine, virus, etc., can solve the problem of animal species limitation, failure to find, attenuation and other problems

Active Publication Date: 2020-11-20
HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Regardless of using traditional passage adaptation technology or modern genetic engineering technology, FMDV attenuation research has encountered an insurmountable obstacle, that is, the attenuated phenotype produced is limited by animal species, and the three Effective m...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant foot-and-mouth disease virus non-toxic strain with heat-resistant phenotypic stable inheritance and negative marker and O/A type foot-and-mouth disease bivalent inactivated vaccine
  • Recombinant foot-and-mouth disease virus non-toxic strain with heat-resistant phenotypic stable inheritance and negative marker and O/A type foot-and-mouth disease bivalent inactivated vaccine
  • Recombinant foot-and-mouth disease virus non-toxic strain with heat-resistant phenotypic stable inheritance and negative marker and O/A type foot-and-mouth disease bivalent inactivated vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] Embodiment 1 FMDV (R4) virus strain is to the evaluation of pig pathogenicity

[0056] Previous studies have found that the IRES chimeric virus FMDV (R4) generated by replacing FMDV IRES domain 4 (IRES-Fd4) with bovine rhinovirus (BRBV) IRES domain 4 (IRES-Bd4) has a 10 6 TCID 50 / The first dose of neck muscle inoculation of natural host pigs does not show any clinical symptoms of foot-and-mouth disease, does not produce viremia, oral and nasal cavity does not shed toxin, and the virus does not induce antibodies in pigs, indicating that the virus has lost replication in susceptible animals For details, please refer to the Chinese invention patent (CN108085302A) and the international PCT patent (application publication number: WO / 2018 / 090994). In order to further evaluate the pathogenicity of FMDV (R4) to pigs, the most sensitive heel intradermal inoculation route was used, and a higher FMDV (R4) inoculation dose (10 7 TCID 50 / head or 10 8 TCID 50 / head), and inoc...

Embodiment 2

[0060] Example 2 Comparison of molecular labeling methods on 3B protein

[0061] In order to construct a molecular marker virus that can be used for differential diagnosis, this experiment conducted a comparative study on the molecular marker methods on the 3B protein. The inventor's laboratory obtained a monoclonal antibody 2H1 against FMDV non-structural protein 3B2 in the previous research, and determined the antigenic epitope it recognizes. The epitope motif is 34 KPLKVK 39 , K 34 、K 37 and V 38 It is the key amino acid of this epitope (CN109295005A, invention patent application number: 201811126187.4). In order to inactivate the epitope recognized by the monoclonal antibody 2H1 and introduce the antigen molecular marker, the key amino acid K of the 2H1 epitope is replaced with alanine (A) at the same time 37 and V 38 , construct the eukaryotic expression plasmid pCI-3B1 of this 3B1 epitope inactivation m twenty three. In addition, the analysis of the antigenicity ...

Embodiment 3

[0062] Example 3 Screening of genetically stable FMDV heat-resistant mutants and determination of molecular determinants of heat-resistant phenotype

[0063] 1 Test method

[0064] 1.1 Thermal stress screening method for foot-and-mouth disease virus

[0065] The thermal pressure screening of the virus is to heat at a specific temperature for 30 minutes to inactivate 99.99% of the virus titer per unit volume, and to carry out repeated heat inactivation tests under the condition of gradually increasing the temperature until the temperature before and after heating Virus titers are approximately the same. Multiple rounds of heat selection were performed at temperatures of 51°C, 53°C, and 56°C until the emergence of highly heat-adapted virus mutants.

[0066] 1.2 Detection method of virus capsid stability

[0067] After the virus is treated at a higher temperature, the proportion of the 146S intact virus capsid is determined, which is a key indicator for judging the thermal sta...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Titeraaaaaaaaaa
Login to view more

Abstract

The invention discloses a recombinant foot-and-mouth disease virus non-toxic strain with heat-resistant phenotypic stable inheritance and a negative marker and an O/A type foot-and-mouth disease bivalent inactivated vaccine. According to the invention, FMDV virus cDNA infectious clone plasmids are constructed, and the plasmids carry a molecular determinant of virus capsid heat-resistant phenotypes, a molecular factor losing replication capacity in vivo, 3A and 3B protein epitope missing negative marker factors and Pst I restriction enzyme cutting sites introduced to two sides of a P1 coding region. The capsid protein coding region of any epidemic strain can be replaced to quickly construct and save the heat-stable and labeled foot-and-mouth disease virus non-toxic strain, and the non-toxicstrain can be used as a foot-and-mouth disease inactivated vaccine seed virus. The universal plasmids are used for constructing two recombinant viruses aiming at two current dominant epidemic strainsand preparing the O/A type foot-and-mouth disease bivalent inactivated vaccine by using the recombinant viruses, and the vaccine is used for immunizing animals to induce high-level neutralizing antibodies and generate immune protection; and the vaccine is used for inoculating animals for antibody detection, and differential diagnosis of the vaccination animals and naturally-infected animals can be realized.

Description

technical field [0001] The present invention relates to virus full-length cDNA infectious cloning plasmid and the recombinant virus strain obtained by rescue using the full-length cDNA infectious cloning plasmid, especially relates to FMDV full-length cDNA infectious cloning plasmid and adopting reverse genetic technology to rescue the heat-resistant surface An avirulent recombinant foot-and-mouth disease virus strain with stable genetics and a negative marker of 3B epitope, the present invention further relates to the preparation of the O / A type foot-and-mouth disease bivalent inactivated vaccine by the recombinant foot-and-mouth disease virus avirulent strain or the preparation of differential diagnosis of foot-and-mouth disease vaccination animals The use in reagents for naturally infecting animals belongs to the field of construction and application of recombinant foot-and-mouth disease virus avirulent strains carrying markers stably in capsids. Background technique [0...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N7/04A61K39/295A61K39/135A61P31/14
CPCC07K14/005C12N7/00A61K39/12A61P31/14C12N2770/32122C12N2770/32162C12N2770/32134A61K2039/5252A61K2039/552
Inventor 于力杨德成王海伟周国辉孙超
Owner HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap